MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2471-2478

  Pigazzi, Martina ^a   Manara, Elena ^a   Baron, Emma ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN A1; CYCLIN B1; CYCLIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; STAT3 PROTEIN; CREB1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL STRAIN HL 60; CELL SURVIVAL; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MICROARRAY; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ACUTE DISEASE; BIOSYNTHESIS; CELL GROWTH; DNA METHYLATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MYELOID LEUKEMIA; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ACUTE DISEASE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA METHYLATION; GENE EXPRESSION; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MICRORNAS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 65549124181     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3404     Document Type: Article

References (49)

1. Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are mieroRNA targets. Cell 2005;120:15-20.
2. Hendriekson DG, Hogan Dj, Herschlag D, Ferrell JE, Brown PO. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS ONE 2008;3: e2126.
3. Ruike Y, Ichimura A, Tsuchiya S, et al. Global correlation analysis for miero-RNA and mRNA expression profiles in human cell lines, j Hum Genet 2008;53:515-23.
4. Papagiannakopoulos T, Kosik KS. MicroRNAs: regulators of oncogenesis and sternness. BMC Med 2008;6:15.
5. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer mieroRNA target sites. Science 2008;320:1643-7.
6. Calin GA, Cimmino A, Fabbri M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008;105:5166-71.
7. Nieoloso MS, Kipps Tj, Croce CM, Calin GA, MicroRNAs in the pathogeny of chronic lymphocytic leukaemia Br j Haematol 2007;139:709-16.
8. Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator mieroRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007;12:457-66.
9. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. Exp Med 2008;205:585-94.
10. Wang XS, Zhang JW. The microRNAs involved in human myeloid differentiation and myelogenous/mye- lohlastic leukemia. J Cell Mol Med 2008;12:1445-55.
11. Schlenk RF, Dörmer K, Krauter j, et al.; German- Austrian Acute Myeloid Leukemia Study Group. Mutations and treatment outcome in cytogenetic ally normal acute myeloid leukemia. N Engl J Med 2008;358:1960-2.
12. Haus-Seuffert P, Meisterernst M. Mechanism of transcriptional activation of cAMP-responsive element binding protein CREB. Mol Cell Biochem 2005;212:5-9.
13. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Mat Rev Mol Cell Biol 2001;2:599-609.
14. Kwok RP, Lundblad JR, Chrivia JC, et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994;370:223-6.
15. Arany Z, Sellers WR, Livingston DM, Eckner R. E1A- associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 1994;77:799-800.
16. Montminy M, Brindle P, Arias j, Ferreri K, Armstrong R. Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism 1996;45: 4-7.
17. Zhang X, Odom DT, Koo SH, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 2005;102: 4459-64.
18. Shankar DB, Cheng JC, Kinjo K, et al. The role of CREB as proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005;7:351-62.
19. Pigazzi M, Ricotti E, Germano G, 1-aggian D, Arico M, Basso G. cAMP response element binding protein (CREB) overexpression in childhood acute lymphoblastic and myeloid leukemia. Haematologica 2007;92: 1435-37.
20. Cheng JC, Kinjo K, judelson DR, et al. CREB is a critical regulator of normal hematopoiesis and leuke- mogenesis. Blood 2008;111:1182-92.
21. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J 2008;14:1.
22. He L, He X, Lowe SW, Harmon GJ. MicroRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007;7:819-22.
23. Bagchi A, Mils AA. The quest for the lp36 tumor suppressor. Cancer Res 2008;68:2551-6.
24. Zhou Z, Flesken-Nikitin A, Corney DC, et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 2006;66: 7889-98.
25. Corney DC, Flesken- Nkitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and MieroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007;67:8433-8.
26. Sun F, Fu H, Liu Q, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008;582:1564-8.
27. ct method. Methods 2001;25:402-8.
28. Toyota M, Suzuki H, Sasaki Y, et al. Epigenetic silencing of mieroRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008;68:4123-32.
29. Espina V, Mehta Al, Winters ME, et al. Protein mieroarrays: molecular profiling technologies for clinical specimens. Proteomics 2003;3:2091-100.
30. Espina V, Wulfkuhle JD, Calvert VS, Petricoin EF III, Liotta LA. Reverse phase protein microarrays for monitoring biological responses. Methods Mol Biol 2007;383:321-36.
31. Garzon R, Volinia S, Liu CG, et al. MieroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008;111:3183-9.
32. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
33. Krek A, Grüm D, Poy MN, et al. Combinatorial mieroRNA target predictions. Nat Genet 2005:37:495- 500.
34. Siu YT, Jin DY. CREB - a real culprit in oncogenesis. FEBS J 2007;274:3224-32.
35. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447: 1130-4.
36. Hermekmg H. p53 enters the microRNA world. Cancer Cell 2007;12:414-8.
37. Kroeger H, Jelinek j, Estecio MR, et al. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 2008;112:1366-73.
38. Rokhlin OW, Scheinker VS, Taghiyev AH Rumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 2008;7:1288-96.
39. He X, He L, Harmon GJ. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 2007;67:11099-101.
40. Chang TC, Wentzel EA, Kent OA, et al. Trans- activation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26: 745-52.
41. VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF III. Reverse-phase protein mieroarrays: application to biomarker discovery and translational medicine. Expert Rev Mol Diagn 2007;7:625-33.
42. Speer R, Wulfkuhle j, Espina % et al. Development of reverse phase protein mieroarrays for clinical applications and patient-tailored therapy. Cancer Genomics Proteomics 2007;4:157-64.
43. Dixon-Mclver A, East P, Mein CA, et al. Distinctive patterns of mieroRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008;3:e2141.
44. Mareucci G, Radmacher MD, Maharry K, et al. MieroRNA expression in cytogenetically normal acute myeloid leukemia N Engl J Med 2008;358:1919-28.
45. Mi S, Lu J, Sun M, et al. MieroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia, Proc Natl Acad Sci U S A 2007;104:19971-6.
46. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk Pj, Löwenberg B. MieroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008;111:5078-85.
47. Langer C, Radmaeher MD, Ruppert AS, et al.; Cancer and Leukemia Group B (CALGB). High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 2008;111: 5371-9.
48. Agarwal S, Kim SW, Ryu SH, Chung WC, Koo JS. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res 2008;68:981-8.
49. Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 2008;20: 460-6.